About LEGENDSPINE
Mission Statement: Provide high quality care through superior spine device development and devices that enhance the surgeon’s ability to improve the patient’s quality of life.
Core Competence: The highly specialized technical and medical staff focus on the development of fusion, non-fusion, and specialized techniques for the spine market in order to assist and aid in the care of patients. Having close relationships with surgeons, manufacturers, regulatory personnel, and testing partners, LEGENDSPINE has a complete model to bring innovation to market.
Our staff brings more than 40 years of spine device knowledge and development to the company’s product innovation, affording them the ability to move quickly to the market and client demands. Our staff has developed and obtained more than 30 patents and guided more than 28 products to market through the FDA approval process.
- History:
- August 2017 LEGENDSPINE was established by engineers, an orthopedic spine surgeon, and business professionals.
- May 2018 LEGENDSPINE received FDA approval for TLIF implant.
- July 2018 LEGENDSPINE implants first TLIF graft.
- August 2019 LEGENDSPINE received approval for ACDF graft.
